Today’s Research Reports on Trending Tickers: OPKO Health and Valeant Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / May 9, 2018 / U.S. markets posted minor changes Tuesday after President Trump announced the U.S. withdrawal from the Iran nuclear deal. The Dow Jones Industrial Average gained 0.01 percent to close at 24,360.21, while the S&P 500 Index declined 0.03 percent to close at 2,671.92. The Nasdaq Composite Index rose 0.02 percent to close at 7,266.90.

“The reason the market is not dramatically selling off is he didn’t close the door to further negotiations, but he also made it clear it would be on [Trump’s] terms,” said Quincy Krosby, chief market strategist at Prudential Financial, according to MarketWatch.

“How far does the U.S. go with the secondary sanctions, that’s the main issue for the market. You have to look at whether the market will punish the European companies who do business with Iran,” said Krosby.

RDI Initiates Coverage on:

OPKO Health, Inc.
https://rdinvesting.com/news/?ticker=OPK

Valeant Pharmaceuticals International, Inc.
https://rdinvesting.com/news/?ticker=VRX

OPKO Health’s stock moved 1.83% lower Tuesday, to close the day at $3.22. The stock recorded a trading volume of 2,091,981 shares, which was below its three months average volume of 4,380,108 shares. In the last year, OPKO Health’s shares have traded in a range of 2.66 – 7.27. The share price has gained 21.05% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.13 is below its 200-day moving average of $4.35. Shares of OPKO Health have gained roughly 4.89 percent in the past month and are down 34.29 percent year-to-date.

Access RDI’s OPKO Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OPK

On Tuesday, shares of Valeant Pharmaceuticals International recorded a trading volume of 55,117,113 shares, which was above the three months average volume of 9,597,040 shares. The stock ended the day 8.87% higher at $19.77. The share price has fallen 19.07% from its 52 week high with a 52 week trading range of 10.94 – 24.43. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $16.82 is below its 200-day moving average of $17.58. Shares of the company are trading at a Price to Earnings ratio of 2.89. Shares of Valeant Pharmaceuticals International have gained roughly 28.04 percent in the past month and are down 4.86 percent year-to-date.

Access RDI’s Valeant Pharmaceuticals International, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=VRX

Our Actionable Research on OPKO Health, Inc. (NASDAQ :OPK) and Valeant Pharmaceuticals International, Inc. (NYSE :VRX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 499065